Cargando…
Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children
An altered ceramide composition in patients with inflammatory bowel disease (IBD) has been reported recently. The aim of this study was to evaluate the concentrations of sphingolipids in the serum of treatment-naive children with newly diagnosed IBD and to determine the diagnostic value of the teste...
Autores principales: | Filimoniuk, Aleksandra, Blachnio-Zabielska, Agnieszka, Imierska, Monika, Lebensztejn, Dariusz Marek, Daniluk, Urszula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408557/ https://www.ncbi.nlm.nih.gov/pubmed/32708181 http://dx.doi.org/10.3390/biom10071083 |
Ejemplares similares
-
Pancreatic Disorders in Children with Inflammatory Bowel Disease
por: Jakimiec, Piotr, et al.
Publicado: (2021) -
Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis—A Preliminary Study
por: Zdanowicz, Katarzyna, et al.
Publicado: (2022) -
Hepatobiliary manifestations of inflammatory bowel disease in children
por: Kucharska, Magdalena, et al.
Publicado: (2019) -
Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease—A Single Center Experience
por: Daniluk, Urszula, et al.
Publicado: (2021) -
The Influence of Physical Activity on the Bioactive Lipids Metabolism in Obesity-Induced Muscle Insulin Resistance
por: Imierska, Monika, et al.
Publicado: (2020)